3//SEC Filing
Daewoong Co., Ltd 3
Accession 0001213900-23-060425
CIK 0001837607other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 7:54 AM ET
Size
5.2 KB
Accession
0001213900-23-060425
Insider Transaction Report
Form 3
Daewoong Co., Ltd
10% Owner
Holdings
- 2,400,000(indirect: Indirect Beneficial Ownership in the 2,400,000 owned by Daewoong Pharmaceutical Co., Ltd)
Common Stock, $0.0001 par value per share
- 4,177,604
Common Stock, $0.0001 par value per share
Footnotes (1)
- [F1]Daewoong Co., Ltd., a company organized under the laws of the Republic of Korea, owns 51% of the outstanding shares of Daewoong Pharmaceutical Co., Ltd., a company organized under the laws of the Republic of Korea; Daewoong Co., Ltd. has voting power and dispositive power over Daewoong Pharmaceutical Co., Ltd. and therefore may be deemed to indirectly own such shares.
Documents
Issuer
AEON Biopharma, Inc.
CIK 0001837607
Entity typeother
IncorporatedKorea, Republic of
Related Parties
1- filerCIK 0001985493
Filing Metadata
- Form type
- 3
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 7:54 AM ET
- Size
- 5.2 KB